Eugia Pharma Inc, Pharmaceutical Import Profile — Canada (DGFT 2022–2026)

Name: Eugia Pharma Inc, Pharmaceutical Import Records from India — 3 Products, $1.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Eugia Pharma Inc, — Pharmaceutical Importer Profile (2026) | 3 Products, $1.4M Trade | TransData Nexus

Eugia Pharma Inc,

Pharmaceutical Importer · Canada · Oncology Focus · $1.4M Total Trade · DGFT Verified

Eugia Pharma Inc, is a pharmaceutical importer based in Canada with a total trade value of $1.4M across 3 products in 3 therapeutic categories. Based on 28 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Eugia Pharma Inc, sources from 2 verified Indian suppliers, with Eugia Pharma Specialities Limited accounting for 79.0% of imports.

Eugia Pharma Inc, — Import Portfolio & Supplier Network

Eugia Pharma Inc, import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Eugia Pharma Inc,?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Eugia Pharma Specialities Limited	$1.6M	42	79.0%
Aurobindo Pharma Limited	$413.2K	16	21.0%

Eugia Pharma Inc, sources from 2 verified Indian suppliers across .

What Formulations Does Eugia Pharma Inc, Import?

Formulation	Value	Ships
Hydralazine hydrochloride injection 20MG/ML (single dose vial) (5708x10's)	$128.9K	3
Hydralazine hydrochloride injection 20MG/ML (single dose vial) (5575x10's)	$127.0K	3
Piperacillin & tazobactam for injection 4.5g(piperacillin and tazobactam for powder for injection 4.0g/0.5g per vial)10s	$86.6K	2
Lidocaine injection, BP 1 % 6960 x 10,7045 x 10 (lidocaine injection BP 1% (10MG/ML)-20ML vial with	$85.4K	2
Ampicillin for injection 1000MG (ampicillin sodium for injection BP 1g) 10's (qty: 13320 pak)	$82.5K	3
Lidocaine injection, BP 2 % 1880 x 10,2659 x 10,3600 x 10,4440 x 10 (lidocaine injection BP 2% (20MG/ML) (20ML with	$77.0K	4
Plerixafor injection, 24 MG/1.2 ML (20 MG/ML) (plerixafor injection - ca) (994 Pack)	$50.0K	1
Ertapenem for injection 1 g/vial (ertapenem for injection 1g/vial)b.n.2ei24226a, mfg dt 11/2024, exp dt	$50.0K	1
Ertapenem for injection 1 g/vial (ertapenem for injection 1g/vial), bt#2ei24245a, mfg#12/2024	$50.0K	1
Irinotecan hydrochloride injection USP,500MG/25ML(irinotecan hydrochloride injection 20MG/ML(500 MG/25ML)canada-eugia	$50.0K	1
Meropenem for injection 1g/vial(meropenem for injection 1g/vial )(batch no:2mi24001a mfg dt 12/2023,exp dt 11/2025)	$50.0K	1
Rocuronium bromide injection 50MG/5ML (rocuronium bromide injection 50 MG/5 ML (10 MG/ML) [multi dose vial]) (2304 x 10	$50.0K	1
Ertapenem for injection 1 g/vial (ertapenem for injection 1g/vial), bt#2ei24039a, mfg#02/2024	$50.0K	1
Ertapenem for injection 1 g/vial (ertapenem for injection 1g/vial), bt#2ei24040a, mfg#02/2024	$50.0K	1
Meropenem for injection 1 g/vial(meropenem for injection 1g/vial)batch nos:2mi24035a m.d.04/2024	$50.0K	1

Eugia Pharma Inc, imports 39 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Irinotecan	Oncology	$700.0K	14	1.7%	4
2	Ertapenem	Advanced Antibiotics	$450.0K	9	0.4%	18
3	Pemetrexed	Advanced Oncology	$250.0K	5	0.9%	11

Eugia Pharma Inc, imports 3 pharmaceutical products across 3 categories into Canada totaling $1.4M.

Eugia Pharma Inc, — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Eugia Pharma Inc. is a privately held pharmaceutical company headquartered in Toronto, Ontario, Canada. Established in 2024, the company specializes in the distribution of generic pharmaceutical products, focusing on both oral solids and injectables. Eugia Pharma offers a distinct advantage to customers through its robust global manufacturing capabilities, efficient supply chain management, and a commitment to developing a wide range of generic products.

The company's mission revolves around improving patient well-being by providing affordable, high-quality generic medicines. Eugia Pharma operates in over 120 countries, leveraging its expertise to deliver healthcare solutions globally. With a team of over 4,000 employees, the company has achieved more than 250 product approvals, underscoring its dedication to advancing healthcare access and promoting well-being on a global scale. (eugiapharma.ca)

2Distribution Network

Eugia Pharma Inc. maintains a centralized distribution network with its primary facility located at 3700 Steeles Avenue West, Suite #402, Woodbridge, Ontario, L4L 8K8, Canada. This strategic location enables efficient logistics and supply chain management across Canada and into international markets. The company's robust global manufacturing capabilities and efficient supply chain management ensure a consistent and reliable supply of pharmaceutical products to meet diverse healthcare needs. (eugiapharma.ca)

3Industry Role

In Canada's pharmaceutical supply chain, Eugia Pharma Inc. functions as a primary wholesaler and distributor of generic pharmaceutical products. By importing a diverse range of generic medications, the company plays a crucial role in enhancing the accessibility and affordability of essential drugs within the Canadian healthcare system. Eugia Pharma's focus on both oral solids and injectables allows it to address a wide array of therapeutic needs, contributing significantly to the country's pharmaceutical distribution landscape. (eugiapharma.ca)

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Eugia Pharma Inc,

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Eugia Pharma Inc. imports finished pharmaceutical formulations exclusively from two Indian suppliers: Eugia Pharma Specialities Limited and Aurobindo Pharma Limited. The majority of shipments (79.0%) are sourced from Eugia Pharma Specialities Limited, while Aurobindo Pharma Limited accounts for 21.0% of shipments. This sourcing pattern indicates a high level of supplier concentration, which could pose risks related to supply chain disruptions or dependency on a limited number of suppliers. However, the strategic choice to concentrate sourcing may also allow for streamlined operations and potentially better pricing agreements. The consistent shipment data over the years suggests a stable and reliable relationship with these suppliers, mitigating some risks associated with high supplier concentration.

2Supply Chain Resilience

Eugia Pharma Inc.'s supply chain resilience is closely tied to its two primary Indian suppliers. The company's reliance on a limited number of suppliers may expose it to risks such as supply disruptions or geopolitical issues affecting trade routes. However, the consistent shipment data over the years indicates a stable and reliable relationship with these suppliers, which is crucial for maintaining a steady supply of pharmaceutical products. The company's focus on efficient supply chain management and its robust global manufacturing capabilities further enhance its ability to navigate potential challenges and ensure the availability of essential medications in the Canadian market.

Importing Pharmaceuticals into Canada — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Canada

1Regulatory Authority & Framework

In Canada, the regulation of pharmaceutical products is overseen by Health Canada, the federal department responsible for promoting and maintaining the health of Canadians. The importation and sale of drugs are governed by the Food and Drugs Act and its associated regulations, which establish the legal framework for ensuring the safety, efficacy, and quality of health products in Canada. These regulations apply to human drugs, medical devices, natural health products, and other health-related products. (canada.ca)

2Import Licensing & GMP

To import pharmaceutical products into Canada, companies must obtain an Establishment Licence (EL) for the activity of importation. The foreign manufacturing site must be listed on the importer's EL. Additionally, imported drugs must have a Drug Identification Number (DIN) assigned by Health Canada, indicating that the product has been authorized for sale in Canada. For natural health products, a Natural Product Number (NPN) or Homeopathic Medicine Number (DIN-HM) is required. Compliance with Good Manufacturing Practice (GMP) standards is mandatory to ensure product quality and safety. (canada.ca)

3Quality & Labeling

Eugia Pharma Inc, — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Eugia Pharma Inc.'s product strategy focuses on importing generic pharmaceutical products across three therapeutic categories: Oncology, Advanced Antibiotics, and Advanced Oncology. The company's top three imported products—Irinotecan, Ertapenem, and Pemetrexed—align with these therapeutic areas, indicating a strategic emphasis on oncology and advanced antibiotic treatments. This focus is driven by the significant market demand for affordable and effective treatments in these critical areas, addressing the needs of patients requiring specialized care.

2Sourcing Profile

Eugia Pharma Inc. employs a sourcing strategy that prioritizes finished pharmaceutical formulations from Indian suppliers, particularly Eugia Pharma Specialities Limited and Aurobindo Pharma Limited. This approach allows the company to leverage India's robust pharmaceutical manufacturing capabilities and cost advantages. By focusing on finished formulations, Eugia Pharma ensures that imported products are ready for distribution, streamlining operations and reducing time to market. This strategy aligns with the company's commitment to providing high-quality, affordable medications to the Canadian market.

3Market Positioning

Seller's Guide — How to Become a Supplier to Eugia Pharma Inc,

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with Eugia Pharma Inc., particularly in the therapeutic areas of oncology and advanced antibiotics. The company's existing sourcing pattern indicates a preference for suppliers that can provide high-quality, finished pharmaceutical formulations. Indian exporters with the capability to meet these standards and align with Eugia Pharma's therapeutic focus areas may find a receptive partner in the Canadian market. Additionally, diversifying the product portfolio to include formulations that address unmet needs in the Canadian market could further enhance the attractiveness of potential partnerships.

2Requirements & Qualifications

Indian exporters seeking to supply Eugia Pharma Inc. and enter the Canadian market must ensure that their products comply with Health Canada's regulatory requirements. This includes obtaining a Drug Identification Number (DIN) for each product, ensuring that the foreign manufacturing site is listed on the importer's Establishment Licence (EL), and adhering to Good Manufacturing Practice (GMP) standards recognized by Health Canada. Additionally, labeling must be in both English and French, and products must meet all applicable quality and safety standards. (canada.ca)

Frequently Asked Questions — Eugia Pharma Inc,

What products does Eugia Pharma Inc, import from India?

Eugia Pharma Inc, imports 3 pharmaceutical products across 3 categories. Top imports: Irinotecan ($700.0K), Ertapenem ($450.0K), Pemetrexed ($250.0K).

Who supplies pharmaceuticals to Eugia Pharma Inc, from India?

Eugia Pharma Inc, sources from 2 verified Indian suppliers. The primary supplier is Eugia Pharma Specialities Limited (79.0% of imports, $1.6M).

What is Eugia Pharma Inc,'s total pharmaceutical import value?

Eugia Pharma Inc,'s total pharmaceutical import value from India is $1.4M, based on 28 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Eugia Pharma Inc, focus on?

Eugia Pharma Inc, imports across 3 categories. The largest: Oncology (50.0%), Advanced Antibiotics (32.1%), Advanced Oncology (17.9%).

Get Full Eugia Pharma Inc, Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.